Exploring The Potential Of Advanced Wound Care Products For Diabetic Wounds
- Volume 26 - Issue 12 - December 2013
- 5242 reads
- 0 comments
Dr. Khan is an Associate Professor within the Division of Medical Sciences at the New York College of Podiatric Medicine.
1. Sheikh ES, Sheikh ES, Fetterolf DE. Use of dehydrated human amniotic membrane allografts to promote healing in patients with refractory non healing wounds. International Wound Journal. 2013; epub ahead of print.
2. Forbes J, Fetterolf DE. Dehydrated amniotic membrane allografts for the treatment of chronic wounds: a case series. J Wound Care. 2012; 21(6):290-6.
3. Warriner R (ed). Wound Treatment Protocol. Diversified Clinical Services Clinical Practice Guidelines. Diversified Clinical Services, 2009.
4. Snyder R. Wound percent area reduction and making decisions about utilizing advanced therapies. Podiatry Manage. 2010; 39(3):197-201.
5. Zelen CM, Serena TE, Denoziere G, Fetterolf DE. A prospective randomized comparative parallel study of amniotic membrane wound graft in the management of diabetic foot ulcers. Int Wound J. 2013; 10(5):502-7.
6. Tengrove NJ, Stacey MC, MacAuley S, et al. Analysis of acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 1999; 7(6):442-452.
7. Lobmann R, Ambrosch A, Schultz G, et. al. Expression of matrix metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia. 2002; 45(7):1011-1016.
8. Southerland JT, Boberg JS, Downey MS, et al (eds). McGlamry’s Comprehensive Textbook of Foot and Ankle Surgery, fourth edition, chapter 69. Lippincott, Williams and Wilkins, Philadelphia, 2013.
9. Davis JW. Skin transplantation with a review of 550 cases at the Johns Hopkins Hospital. Johns Hopkins Med J. 1910; 15:307-96.
10. Stern M. The grafting of preserved amniotic membrane to burned and ulcerated surfaces, substituting skin grafts. JAMA. 1923; 60:973.
11. Sabella N. Use of fetal membranes in skin grafting. Med Records NY. 1913; 83:478-80.
12. Nordack PH, Miettinen S, Kääriäinen M, et al Amniotic membrane reduces wound size in early stages of the healing process. J Wound Care. 2012; 21(4):190-197.
13. Trelford JD, Trelford-Sauder M. The amnioin in surgery, past and present. Am J Obstet Gynecol. 1979; 134(7):833-845.
14. Zhang Y, Li C, Jiang S, et al. Human placenta-derived mesenchymal progenitor cells support culture expansion of long-term culture- initiating cells from cord blood CD34+ cells. Exp Hematol. 2004; 32(7):657–664.
15. Solomon A, Wajngarten M, Alviano F, et al. Suppression of inflammatory and fibrotic responses in an in-vitro model of allergic inflammation by the amniotic membrane stromal matrix. Clin Exp Allergy. 2005; 35(7):941-948.
16. Trelford JD, Anderson DG, Hanson FW, et al. Consideration of the amnion as an autograft and as an allograft in sheep. A preliminary report. J Med. 1972; 3(4):231.
17. Robson MC, Chandrasekharam V. Use of human and bovine amnion as a biological dressing. Arch Surg 1981; 116(7):891.
18. Niknejad H, Pierovi H, Jorjani M, et al. Properties of the amniotic membrane for potential use in tissue engineering. Eur Cells Mater. 2008; 15:88-99
19. Werber B, Martin E. A prospective study of 20 foot and ankle wounds treated with cryopreserved amniotic membrane and fluid allograft. J Foot Ankle Surg. 2013; 52(5):615-21.
20. Lim LS, Poh RW, Riau AK, et al. Biological and ultrastructural properties of Acelegraft, a freeze-dried γ-irradiated human amniotic membrane. Arch Ophthalmol. 2010; 128(10):1303-1310.
For further reading, see “Amniotic Membrane: Does It Have Promise For Diabetic Foot Ulcers?” in the June 2013 issue of Podiatry Today.